Back
Bio-Rad Laboratories, Inc. 10K Form
Sell
20
BIO
Bio-Rad Laboratories, Inc.
Last Price:
$256.80
Seasonality Move:
9.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BIO News And Ratings
See the #1 stock for the next 7 days that we like better than BIO
BIO Financial Statistics
Sales & Book Value
| Annual Sales: | $2.6B |
|---|---|
| Cash Flow: | $164.9M |
| Price / Cash Flow: | 13.15 |
| Annual Sales: | $249.75 |
| Price / Book: | 1.03 |
Profitability
| EPS (TTM): | 27.91200 |
|---|---|
| Net Income (TTM): | $759.9M |
| Gross Margin: | $1.3B |
| Return on Equity: | 10.99% |
| Return on Assets: | 7.7% |
Bio-Rad Laboratories, Inc. Earnings Forecast
Key Bio-Rad Laboratories, Inc. Financial Ratios
-
The Gross Profit Margin over the past 46 years for BIO is 52.01%.
-
The Selling, General & Administrative Expenses for BIO have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 9.97% of Revenue.
-
The Interest Expense is 6.45% of Operating Income.
-
The Net Earning history of BIO is 29.42% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 22 years.
Bio-Rad Laboratories, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | BIO |
| CUSIP: | 090572 |
| Website: | bio-rad.com |
Debt
| Debt-to-Equity Ratio: | 0.16 |
|---|---|
| Current Ratio: | 5.62 |
| Quick Ratio: | 3.87 |
Price-to-Earnings
| Trailing P/E Ratio: | 9.21 |
|---|---|
| Forward P/E Ratio: | 24.02 |
BIO Technical Analysis vs Fundamental Analysis
Sell
20
Bio-Rad Laboratories, Inc. (BIO)
is a Sell
Is Bio-Rad Laboratories, Inc. a Buy or a Sell?
-
Bio-Rad Laboratories, Inc. stock is rated a SellThe current Bio-Rad Laboratories, Inc. [BIO] share price is $256.56. The Score for BIO is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.